Pramipexole Hyperactivates the External Globus Pallidus and Impairs Decision-Making in a Mouse Model of Parkinson’s Disease
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168849 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hisayoshi Kubota und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake 470-1192, Aichi, Japan. Hauptthemen laut MEDLINE: Pramipexole, Disease Models, Animal, Parkinson Disease, Decision Making. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Faculty research grant of Fujita Health University.
Abstract (Originalsprache)
In patients with Parkinson’s disease (PD), dopamine replacement therapy with dopamine D2/D3 receptor agonists induces impairments in decision-making, including pathological gambling. The neurobiological mechanisms underlying these adverse effects remain elusive. Here, in a mouse model of PD, we investigated the effects of the dopamine D3 receptor (D3R)-preferring agonist pramipexole (PPX) on decision-making. PD model mice were generated using a bilateral injection of the toxin 6-hydroxydopamine into the dorsolateral striatum. Subsequent treatment with PPX increased disadvantageous choices characterized by a high-risk/high-reward in the touchscreen-based Iowa Gambling Task. This effect was blocked by treatment with the selective D3R antagonist PG-01037. In model mice treated with PPX, the number of c-Fos-positive cells was increased in the external globus pallidus (GPe), indicating dysregulation of the indirect pathway in the corticothalamic-basal ganglia circuitry. In accordance, chemogenetic inhibition of the GPe restored normal c-Fos activation and rescued PPX-induced disadvantageous choices. These findings demonstrate that the hyperactivation of GPe neurons in the indirect pathway impairs decision-making in PD model mice. The results provide a candidate mechanism and therapeutic target for pathological gambling observed during D2/D3 receptor pharmacotherapy in PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake 470-1192, Aichi, Japan.
- Department of Neurology, School of Medicine, Fujita Health University, Toyoake 470-1192, Aichi, Japan.
ORCID-Profile: Xinjian Zhang, Hirohisa Watanabe, Taku Nagai
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Faculty research grant of Fujita Health University
- The Hori Sciences and Arts Foundation
- AMED
- JSPS KAKENHI
- Hori Sciences and Arts Foundation
Zitieren
APA
Kubota, H., Zhou, X., Zhang, X., Watanabe, H., & Nagai, T. (2024). Pramipexole Hyperactivates the External Globus Pallidus and Impairs Decision-Making in a Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168849
Vancouver
Kubota H, Zhou X, Zhang X, Watanabe H, Nagai T. Pramipexole Hyperactivates the External Globus Pallidus and Impairs Decision-Making in a Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168849
BibTeX
@article{Kubota2024,
author = {Kubota, Hisayoshi and Zhou, Xinzhu and Zhang, Xinjian and Watanabe, Hirohisa and Nagai, Taku},
title = {Pramipexole Hyperactivates the External Globus Pallidus and Impairs Decision-Making in a Mouse Model of Parkinson’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168849}
}
EUVIMED